Quality Resource Guide l Management of the Substance Use Disorder Dental Patient 2nd Edition 9 www.metdental.com References 1. Abuse and Mental Substance Health Services Administration. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/ 2. National Drug Intelligence Center. The Economic Impact of Illicit Drug Use on American Society. Washington DC, 2011. 3. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009;373(96283):2222-2233. 4. U.S. Department of Health and Human Services, Center of Disease Control and Prevention. Best Practices for Comprehensive Tobacco Control Programs-2014. Atlanta GA, 2014. 5. Centers for Disease Control and Prevention (CDC). Alcohol-Related Disease Impact. Atlanta GA, 2010. 6. U.S. Department of Health and Human Services, Centers for Chronic Disease Prevention and Health Promotion. The Health Consequences of Smoking-50 years of Progress: A Report of the Surgeon General. Atlanta GA, 2014. 7. Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Ann Rev Public Health. 2015; 36:559–574 8. Substance Abuse and Mental Health Services Administration (SAMHSA). SAMHSA. BHSIS Series S-71. Rockville, MD: 2014. Treatment Episode Data Set (TEDS): 2000–2012. National Admissions to Substance Abuse Treatment Services. 9. McCauley JL, Leite RS, Melvin CL, Fillingim RB, Brady KT. Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider- level intervention. Subst Abus. 2016; 37(1): 9–14. doi:10.1080/08897077.2015.1127870. 10. McCauley JL, Leite RS, Gordan VV, Fillingim RB, Gilbert GH, Meyerowitz C, Cochran D, Rindal DB, Brady KT. Opioid prescribing and risk mitigation implementation in the management of acute pain Results from The National Dental Practice-Based Research Network. Available at: https://doi.org/10.1016/j. adaj.2017.11.031 11. Hart CL, Ksir C, Oakley R. Drugs, Society and Human Behavior, Ed 13. New York: McGraw- Hill Companies Inc, 2009. 12. National Institutes of Drug Abuse. Drugs, brains, and behavior: The science of addiction. Bethesda MD: (NIH Pub No. 07-5605), 2007. 13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition, Washington DC, 2013. 14. Fowler JS, Volkow ND, Kassed CA, Chang L. Imaging the addicted human brain. Sci Pract Perspect 2007; 3(2):4-16. 15. Yucel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, Lubman DL. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 2008; 65(6):694-701. 16. McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284(13):1689-1695. 17. Helms RA, Quan DJ, Herfindal ET, Gourley DR. Textbook of Therapeutics: Drug and Dsease Management, Ed. 8. Philadelphia: Lippincott Williams and Wilkins; 2006. 18. Nestler EJ, Malenka RC. The addicted brain. Sci Am 2004; 290(3):78-85. 19. National Institute on Drug Abuse. Preventing Drug Use Among Children and Adolescents: A Research-Based Guide for Parents, Educators, and Community Leaders. Ed 2; p. 8-9, 2003. 20. NIH National Institute on Drug Abuse. Drugs, Brains and Behavior, the Science of Addiction; Revised July 2014. 21. Rappaport, SC. Dental management of the drug abuser. NY State Dent J 1972; 38(8):485- 491. 22. Curtis E. Meth mouth: A review of methamphetamine abuse and its oral manifestations. Gen Dent 2006; 54(2):125-129. 23. Bassiouny MA, Yang J. Influence of drinking patterns of carbonated beverages on dental erosion. Gen Dent 2005; 53(3):205-210. 24. Lineberry TW, Bostwick JM. Methamphetamine abuse: A perfect storm of complications. Mayo Clin Proc 2006; 81(1):77-84. 25. McGrath C, Chan B. Oral health sensations associated with illicit drug abuse. Br Dent J 2005; 198(3):159-162. 26. Adyin E, Gokoglu O, Ozcurumez G, Aydin H. Factitious cheilitis: A case report. J Med Case Report 2008; 2(29):1-4. 27. Larato DC. Oral tissue changes in the chronic alcoholic. J Periodontol 1972; 43(12):772-773. 28. Borsanyi SJ. Chronic asymptomatic enlargement of the parotid glands. Ann Otol Rhinol Laryngol 1962; 71:857-867. 29. Friedlander AH, Mills MJ. The dental management of the drug-dependent patient. Oral Surg Oral Med Oral Pathol 1985; 60(5):489-492. 30. Kimbrough HM Jr. Local anesthetic in the addictive patient. Tex Dent J 1975;93(5):7-9. 31. American Dental Association. ADA/PDR guide to dental therapeutics, Ed 4, Chicago, 2006. 32. Rees TD. Oral effects of drug abuse. Crit Rev Oral Biol Med 1992; 3(3):163-184. 33. Lee CY, Mohammadi H, Dixon RA. Medical and dental implications of cocaine abuse. J Oral Maxillofac Surg 1991; 49(3):290-293. 34. Center for Disease Control and Prevention: CDC 24/7: Saving Lives, Protecting People website: CDC >Opioid Overdose >Opioid Basics >Addictions and Overdose https://www. cdc.gov/drugoverdose/opioids/prescribed.html